Čeština 
Slovenčina 
Română 
Deutsch REXTOL 5MCG/ML
Prevetion and treatment of secondary hyperparathyroidism (HPT) in adult patients with end-stage renal disease (ESRD) who are on haemodialysis.
THERAPEUTIC INDICATIONS
Prevetion and treatment of secondary hyperparathyroidism (HPT) in adult patients with end-stage renal disease (ESRD) who are on haemodialysis.
Rextol 5 mcg/ml
- Each 1 ml ampoule dej vial contains 5 micrograms of paricalcitol.
- Each 2 ml ampoule dej vial contains 10 micrograms of paricalcitol.
DISPENSING AND REIMBURSEMENT
Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.
Mandatory information
